Cargando…
The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571428/ https://www.ncbi.nlm.nih.gov/pubmed/31169685 http://dx.doi.org/10.1097/MD.0000000000015833 |
_version_ | 1783427414054928384 |
---|---|
author | Zhang, Chuanlin Zhang, Zeju Mi, Jie Wang, Xueqin Zou, Yujun Chen, Xiaoya Nie, Zhi Luo, Xinyi Gan, Ruiying |
author_facet | Zhang, Chuanlin Zhang, Zeju Mi, Jie Wang, Xueqin Zou, Yujun Chen, Xiaoya Nie, Zhi Luo, Xinyi Gan, Ruiying |
author_sort | Zhang, Chuanlin |
collection | PubMed |
description | Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and risk factors of ICU-acquired VTE for those populations. We prospectively studied 281 consecutively included patients in the ICU at a single center. All patients provided informed consent. Patients received ultrasound evaluation and were followed for VTE before ICU discharge or within 28 days of ICU stay. The type of VTE thromboprophylaxis was also recorded for all patients. Variables from univariate analyses that were associated with VTE were included in the binary logistic regression analysis to determine VTE predictors. The cumulative VTE incidence with 95% confidence interval (CI) was estimated using Kaplan–Meier methods. Patients had a median age of 60 years (range, 18–89) and an acute physiology and chronic health evaluation II score of 17 (range, 4–36). Despite all patients receiving guideline-recommended thromboprophylaxis, the cumulative incidence of VTE at 7, 14, 21, and 28 days was 4.45% (95% CI 2.55–7.71), 7.14% (95% CI 4.61–10.97), 7.53% (95% CI 4.92–11.43), and 9.55% (95% CI 6.55–13.81), respectively. Central venous catheter use (P = .002, odds ratio [OR] = 4.50), Caprini score (P = .012, OR = 1.20), and ICU length of stay (P = .006, OR = 1.08) were independent risk factors related to the incidence of VTE for patients admitted to the ICU. Our prospective observational study found that the 28-day cumulative incidence of VTE was relatively high for patients admitted to the ICU, despite the use of guideline-recommended thromboprophylaxis. Patients with femoral central venous catheter, prolonged ICU length of stay, or a high Caprini score may have an increased risk of developing VTE. |
format | Online Article Text |
id | pubmed-6571428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-65714282019-07-22 The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis Zhang, Chuanlin Zhang, Zeju Mi, Jie Wang, Xueqin Zou, Yujun Chen, Xiaoya Nie, Zhi Luo, Xinyi Gan, Ruiying Medicine (Baltimore) Research Article Few prospective studies have reported the cumulative incidence of venous thromboembolism (VTE) in the intensive care unit (ICU), especially for patients receiving guideline-recommended VTE prophylaxis. We aimed to design a prospective observational study to investigate the cumulative incidence and risk factors of ICU-acquired VTE for those populations. We prospectively studied 281 consecutively included patients in the ICU at a single center. All patients provided informed consent. Patients received ultrasound evaluation and were followed for VTE before ICU discharge or within 28 days of ICU stay. The type of VTE thromboprophylaxis was also recorded for all patients. Variables from univariate analyses that were associated with VTE were included in the binary logistic regression analysis to determine VTE predictors. The cumulative VTE incidence with 95% confidence interval (CI) was estimated using Kaplan–Meier methods. Patients had a median age of 60 years (range, 18–89) and an acute physiology and chronic health evaluation II score of 17 (range, 4–36). Despite all patients receiving guideline-recommended thromboprophylaxis, the cumulative incidence of VTE at 7, 14, 21, and 28 days was 4.45% (95% CI 2.55–7.71), 7.14% (95% CI 4.61–10.97), 7.53% (95% CI 4.92–11.43), and 9.55% (95% CI 6.55–13.81), respectively. Central venous catheter use (P = .002, odds ratio [OR] = 4.50), Caprini score (P = .012, OR = 1.20), and ICU length of stay (P = .006, OR = 1.08) were independent risk factors related to the incidence of VTE for patients admitted to the ICU. Our prospective observational study found that the 28-day cumulative incidence of VTE was relatively high for patients admitted to the ICU, despite the use of guideline-recommended thromboprophylaxis. Patients with femoral central venous catheter, prolonged ICU length of stay, or a high Caprini score may have an increased risk of developing VTE. Wolters Kluwer Health 2019-06-07 /pmc/articles/PMC6571428/ /pubmed/31169685 http://dx.doi.org/10.1097/MD.0000000000015833 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Zhang, Chuanlin Zhang, Zeju Mi, Jie Wang, Xueqin Zou, Yujun Chen, Xiaoya Nie, Zhi Luo, Xinyi Gan, Ruiying The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title | The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title_full | The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title_fullStr | The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title_full_unstemmed | The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title_short | The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
title_sort | cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571428/ https://www.ncbi.nlm.nih.gov/pubmed/31169685 http://dx.doi.org/10.1097/MD.0000000000015833 |
work_keys_str_mv | AT zhangchuanlin thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT zhangzeju thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT mijie thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT wangxueqin thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT zouyujun thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT chenxiaoya thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT niezhi thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT luoxinyi thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT ganruiying thecumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT zhangchuanlin cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT zhangzeju cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT mijie cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT wangxueqin cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT zouyujun cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT chenxiaoya cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT niezhi cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT luoxinyi cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis AT ganruiying cumulativevenousthromboembolismincidenceandriskfactorsinintensivecarepatientsreceivingtheguidelinerecommendedthromboprophylaxis |